Warsaw, Poland-based Medicalgorithmics designed the state-of-the-art, wearable device to measure individual ECG signals and obtain accurate cardiac arrhythmia diagnoses across up to 15 days of monitoring sessions.
According to a news release, Medicalgorithmics’ Qpatch has been selected for a clinical trial to be conducted by leading research centers as part of the Cardiac Surgery Research Network (CTSN), with funding provided by the National Heart, Lung and Blood Institute (NHLBI) and the National Institutes of Health (NIH).
Qpatch features an eInk screen to facilitate interaction with the wearable for the patients and physicians. The real-time ECG reading provided by the device can be observed via near-field communication on a smartphone to allow for ongoing quality control of the recorded ECG signal.<…